Alkermes
ALKS
#2383
Rank
NZ$13.81 B
Marketcap
NZ$82.21
Share price
3.05%
Change (1 day)
41.67%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2023 (TTM): NZ$2.15

According to Alkermes's latest financial reports the company's current EPS (TTM) is NZ$0.72. In 2022 the company made an earnings per share (EPS) of NZ-$1.72 a decrease over its 2021 EPS that were of NZ-$0.54.

EPS history for Alkermes from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$2.15-224.94%
2022NZ-$1.72220%
2021NZ-$0.54-57.19%
2020NZ-$1.26-44.38%
2019NZ-$2.2641.57%
2018NZ-$1.59-13.59%
2017NZ-$1.84-24.82%
2016NZ-$2.45-9.87%
2015NZ-$2.72660%
2014NZ-$0.36-242.86%
2013NZ$0.25-137.84%
2012NZ-$0.66-39.34%
2011NZ-$1.0924.49%
2010NZ-$0.8819.51%
2009NZ-$0.73-130.37%
2008NZ$2.42-27.81%
2007NZ$3.351600%
2006NZ$0.20-164.71%
2005NZ-$0.30-81.91%
2004NZ-$1.68-40.88%
2003NZ-$2.858.9%
2002NZ-$2.6175.9%
2001NZ-$1.493.75%
2000NZ-$1.43-37.98%
1999NZ-$2.3177.93%
1998NZ-$1.30123.08%
1997NZ-$0.58-43.97%
1996NZ-$1.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.97 1,571.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.40 1,212.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.36 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.41 375.73%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$8.10 1,030.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.96 1,570.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
NZ-$90.11-12,677.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$1.13 57.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel